DLDylan Lee

Dylan Lee

*This is an algorithmically generated author record based on publicly available information.

Dylan Lee has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrated Bile Metabolomics and Serum Biomarkers for Differentiating Cholangiocarcinoma from Cholelithiasis

    by Jinduo Zhang, Leiqing Wang, Xu Zhang, Ping Yue, Boru Jin, Ningning Mi, Jinyu Zhao, Long Gao, Dylan Lee, Yanyan Lin, et al.

    Background: We investigated bile metabolites and serum variables for differentiating cholangiocarcinoma (CCA) from cholelithiasis. Methods: Bile from 31 patients with CCA and 48 with cholelithiasis was profiled by high-resolution LC-MS. Candidate metabolites and serum variables were integrated in a seven-variable classifier, and public single-cell data provided tissue-level biological context. Results: Of 2269 annotated metabolite features, 532 met the exploratory screening criteria. The selected signature comprised pyruvic acid, lipoxin A4, CEA, APOA1, 3-chloro-L-tyrosine, ADP-ribose, and glutaric acid; pyruvic acid had the largest contribution in the SHAP analysis. Random forest achieved an AUC of 0.894 in the classifier comparison, a training cross-validation AUC of 0.820, and an AUC of 0.914 in the 16-patient test subset. Because selection used all 79 patients before evaluation, these internal performance estimates may be optimistic. Conclusions: Integrated bile and serum profiling identified a promising seven-variable signature for differentiating CCA from cholelithiasis in this cohort. Added diagnostic value over routine serum markers and performance in other benign biliary conditions have not been established.

  • Introduction: The Political Economy of Global Healthcare Industries

    by Dylan Lee, Tina Lee

    This introduction chapter outlines the conceptual foundations and purpose of the volume The Political Economy of Global Healthcare Industries: States, Markets, and Power. It situates the globalization of healthcare within broader transformations of twenty-first-century capitalism and explains how this volume analyzes healthcare as both an economic system and a moral order. Drawing on political economy, the chapter examines how states, markets, and power interact to shape innovation, regulation, and inequality across global health industries. It highlights key themes of the book—financialization, industrial policy, digitalization, and health security—while establishing the analytical framework linking macroeconomic structures to ethical and institutional dimensions of governance. This chapter provides readers with the theoretical context, scope, and objectives that guide the contributions that follow.

  • Pandemic Lessons

    by Tina Lee, Luna Lee, Chenxiao Hu, Dylan Lee

    This chapter examines the COVID-19 pandemic as a systemic stress test of global health governance, revealing the tensions between state sovereignty, market logic, and multilateral solidarity. It situates pandemic responses within the broader political economy of healthcare, analyzing how intellectual property regimes, supply-chain concentration, and fiscal asymmetries shaped inequities in access to vaccines, diagnostics, and therapeutics. Comparative case studies from the United States, China, and low- and middle-income countries illustrate divergent outcomes arising from variations in state capacity, industrial policy, and social protection. The chapter argues that pandemic resilience requires reimagining health as a global public good, diversifying regional production, reforming intellectual-property frameworks, and embedding equity into international law. Through an integrated analysis of governance, finance, and justice, it proposes a new paradigm of cooperative preparedness grounded in transparency, inclusivity, and sustainable solidarity.


  • Geographic and Demographic Trends in Allergen Sensitization: Evidence From a Nationwide Chinese Cohort

    by Haiqing Gao, Li Ma, Ying Zhao, Aiyuan Zhang, Zihua Chen, Lanting Wang, Zhen Zhang, Shengan Chen, Fanping Yang, Yu Xu, et al.

    Background: The increasing prevalence of allergic diseases in China necessitates a comprehensive understanding of allergen sensitization patterns to inform effective public health strategies and clinical management. Objective: This nationwide cross‐sectional study aimed to identify allergen sensitization profiles, demographic variations, and regional disparities among Chinese patients. Methods: Data from 33,308 initial outpatient visits between 2021 and 2024 were analyzed. Sensitization to 25 common allergens was assessed using the ImmunoCAP system. Demographic and geographic factors, including age, gender, and regional distributions, were evaluated for their impact on allergen sensitization. Results: Dermatophagoides pteronyssinus ( D. pteronyssinus ) and Dermatophagoides farinae ( D. farinae ) were the predominant aeroallergens, sensitizing 48% of patients. Significant regional variation was observed, with South China showing the highest sensitization rates to D. farinae (63.51%) compared to the Northwest (36.95%). Among food allergens, shrimp (17.22%) and crab (11.85%) were most common, especially in adolescents aged 13–18 years. Polysensitization was prevalent in patients with atopic dermatitis (63.79%). Gender differences revealed higher sensitization rates among males. Regional disparities underscored the need for geographically customized health interventions. Conclusions: This study provides critical insights into allergen sensitization patterns across China, emphasizing the importance of tailored public health strategies and personalized immunotherapy to improve allergic disease management. Findings contribute to the global understanding of allergic disease epidemiology and foster advancements in prevention, diagnosis, and treatment strategies.


  • Migrant Leadership in Cross-Border Biotech and Health Innovation

    by Tina Lee, Luna Lee, Chenxiao Hu, Nicolas Melin, Laure C. Bouchez, Dylan Lee

    This chapter, per the authors, reframes migrant founders as institutional architects who assemble cross-border biomedical pipelines to correct misalignments between national innovation systems and transnational health needs. It introduces Transnational Corrective Innovation and tests six propositions linking dual-regime regulatory fluency, diaspora-anchored finance, early multi-ancestry evidence, capability-based geographic unbundling, privacy-preserving data design, and regulatory reliance to measurable gains in time-to-trial, capital inflection, evidence quality, AI validation, and multi-market access. Using a comparative, de-identified multi-case design (2017–2025) across therapeutics, digital epidemiology, and diagnostics, the chapter operationalizes lean indicators from public, auditable sources. Findings show earlier first-in-human starts, faster institutional financing, fewer representativeness queries, accelerated validation under GDPR and the AI Act, and shorter secondary approval lags, with policy and governance templates distilled for regulators, funders, and universities.

  • Open Access

    Rifaximin Plus Probiotics Reshape Gut Microbiota, Serum Propionate, and Mucosal Immunity in Cirrhosis‐Related Hepatic Encephalopathy Microbiota‐Immune Remodeling in HE

    by Yiping Wang, Hui Zhu, Shujun Wang, Danni Hu, Mengdan Xu, Luna Lee, Dylan Lee

    Background: Hepatic encephalopathy (HE) remains a major cause of hospitalization and readmission in cirrhosis and is closely linked to hyperammonemia, microbial dysbiosis, impaired short‐chain fatty acid (SCFA) output, barrier dysfunction, and altered mucosal immunity. We evaluated whether adding a multistrain probiotic to rifaximin was associated with greater neurometabolic improvement and coordinated gut–liver–brain axis changes. Methods: In this prospective, 6‐month, randomized, open‐label, assessor‐blinded, three‐arm controlled study, 61 adults with cirrhosis‐related HE received standard care alone (Con, n = 20), standard care plus rifaximin 550 mg twice daily (Rif, n = 20), or rifaximin plus a multistrain probiotic (1 × 10^9 CFU three times daily; Rif + Pro, n = 21). The main prespecified biochemical readout was serum ammonia at Month 6. A composite HE index incorporating mental status, flapping tremor, number connection test, and ammonia grade was analyzed as a prespecified exploratory neurometabolic score. A predefined mechanistic subset underwent 16S rRNA microbiome profiling, serum SCFA measurement, and fecal secretory IgA (SIgA) testing. Results: Baseline characteristics did not differ across arms. Post‐treatment serum ammonia decreased in a graded pattern (Con 177 ± 43.2, Rif 143 ± 37.5, Rif + Pro 117 ± 34.3 μmol/L), with parallel improvement in the exploratory HE index (10.0 ± 4.9, 5.3 ± 4.7, and 3.7 ± 4.1, respectively). In the mechanistic subset, the microbial community structure differed by treatment (PERMANOVA p = 0.006). Rif + Pro was associated with higher serum propionate, increased Lactobacillus salivarius–associated signal, reduced Bacteroides ovatus–associated signal, and marked fecal SIgA elevation compared with standard care or rifaximin alone. The SIgA–propionate relationship was interpreted as exploratory. Conclusions: Rifaximin plus multistrain probiotics was associated with greater improvement in serum ammonia and exploratory HE severity readouts than rifaximin alone, accompanied by coordinated microbial, metabolic, and mucosal immune changes. These findings support confirmation in adequately powered event‐driven trials with strain‐resolved profiling and targeted metabolomics.

  • Isolation in White Coats

    by Tina Lee, Luna Lee, Chenxiao Hu, Nicolas Melin, Laure C. Bouchez, Dylan Lee

    This chapter reframes loneliness among globally mobile healthcare professionals as a structural outcome of political economy rather than an individual shortcoming. Using an interdisciplinary review and a U.S–China comparison (with selective UK references), it traces how migration regimes, credentialing bottlenecks, institutional hierarchies, and market logics jointly produce isolation among migrant clinicians. Four interlocking dynamics emerge—bureaucratic precarity, emotional dislocation, professional invisibility, and commodification of care—each linked to burnout, attrition, and underused cultural–linguistic assets. We translate this synthesis into multi-level remedies: institution-level onboarding, mentorship, mental-health supports, and anti-bias systems; national reforms to visas, fair-contract enforcement, and credential recognition; and cross-border adherence to the WHO Code, bilateral supports, and better migration data.